This week, the company settled a deceptive marketing case with 42 states and the District of Columbia, but did not admit any wrongdoing. the governments will share a $33 million settlement from McNeil, and impose limits on how the company can advertise its products.
MA will get $900,000 in a settlement resulting from an investigation into New Jersey home health product giant Johnson & Johnson's alleged misrepresentation of the quality of certain over-the-counter drugs.
To view the full article, register now.More news: Philippine official downplays alleged China war threats
"All New Mexicans deserve access to quality, affordable healthcare, and that includes the over-the-counter medications our children and families rely on every day for their health", said Attorney General Balderas.
A $33 million multi-state settlement with Johnson & Johnson Consumer Inc. and Johnson & Johnson has been reached, with Idaho claiming just more than $430,000 of the settlement.
"The deceitful actions of Johnson & Johnson resulted in recalls of some of the most common over-the-counter medicines that Arkansans use". After settling criminal charges, now the company has now settled allegations that it marketed these products deceptively when claiming that it followed good manufacturing processes.More news: Philippines' Duterte leaves for 4-day visit to Russia
Represent on its websites that the over-the-counter products manufacturing facilities meet current GMP as outlined by the FDA if McNeil has had a Class I or Class II recall of over-the-counter drug products within the prior 12 months. The recalls came amid reports of product oddities, including unusual odors and particles found in liquid medicines that the company produced.
Attorneys general from Pennsylvania and Texas led the litigation.More news: Beijing's new weapon in economic war: Chinese tourists
The Health Care Section protects the public and consumers from unfair health care practices.